- Research works
- 88 ▲ 25% vs 2013–17
- Citations
- 831 9.5 per fractional work
- Top-10% rate
- 18.0% record average 16.5%
- Open access
- 39% world 28%
Not ranked overall: Johnson & Johnson (Switzerland) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Chemistry, 2.9×. Every wedge is a field page.
- Chemistry 2.9×
- Medicine 2.6×
- Immunology and Microbiology 2.0×
- Biochemistry, Genetics and Molecular Biology 1.6×
- Pharmacology, Toxicology and Pharmaceutics 1.6×
- Health Professions 1.1×
- Neuroscience 0.8×
- Agricultural and Biological Sciences 0.8×
- Earth and Planetary Sciences 0.8×
- Economics, Econometrics and Finance 0.7×
- Engineering 0.6×
- Computer Science 0.6×
- Decision Sciences 0.5×
- Psychology 0.5×
- Physics and Astronomy 0.4×
- Business, Management and Accounting 0.4×
- Environmental Science 0.4×
- Social Sciences 0.3×
Who are the top researchers at Johnson & Johnson (Switzerland)?
Ranked on the composite score, K. Buesch lead among researchers whose main affiliation is Johnson & Johnson (Switzerland).
- 1 K. Buesch Switzerland · #1,362,508 worldwide 26 citations · 21 works
Which keywords describe research at Johnson & Johnson (Switzerland)?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Endothelial Dysfunction, Echocardiography, Treatment Guidelines, Pulmonary Hypertension, Right Heart Assessment, Guidelines, Immunosuppression and Risk Factors.
- Treatment
- Merkel Cell Carcinoma
- Immunosuppression
- Epidemiology
- Guidelines
- Pulmonary Hypertension
- Echocardiography
- Endothelial Dysfunction
- Treatment Guidelines
- Right Heart Assessment
- Risk Factors
- Diagnosis
- Mortality
- Polyomavirus
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 14 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 14 words, with their numbers
- Endothelial Dysfunction3▲ 40×4 topics
- Echocardiography3▲ 32×4 topics
- Treatment Guidelines3▲ 39×4 topics
- Pulmonary Hypertension2▲ 55×1 topic
- Right Heart Assessment2▲ 192×1 topic
- Guidelines2▲ 9.7×7 topics
- Risk Factors2▲ 4.2×7 topics
- Epidemiology1◆ 0.99×12 topics
- Diagnosis1▲ 3.9×6 topics
- Immunosuppression1▲ 38×2 topics
- Mortality1▲ 5.5×3 topics
- Merkel Cell Carcinoma1▲ 204×1 topic
- Polyomavirus1▲ 204×1 topic
- Treatment1▲ 2.5×5 topics
Which research topics does Johnson & Johnson (Switzerland) publish most on?
By volume in 2022–2025: Pulmonary Hypertension Research and Treatments, Polyomavirus and related diseases, Colorectal Cancer Screening and Detection and Coleoptera Taxonomy and Distribution.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Pulmonary Hypertension Research and Treatments Pulmonary and Respiratory Medicine 2 works
- 2 Polyomavirus and related diseases Oncology 1 works
- 3 Colorectal Cancer Screening and Detection Oncology 1 works
- 4 Coleoptera Taxonomy and Distribution Ecology, Evolution, Behavior and Systematics 1 works
- 5 Cyclopropane Reaction Mechanisms Organic Chemistry 0 works
- 6 Amyotrophic Lateral Sclerosis Research Neurology 0 works
- 7 Phosphodiesterase function and regulation Molecular Biology 0 works
- 8 Scarabaeidae Beetle Taxonomy and Biogeography Paleontology 0 works
- 9 Cardiac Arrhythmias and Treatments Cardiology and Cardiovascular Medicine 0 works
- 10 Advanced biosensing and bioanalysis techniques Molecular Biology 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Johnson & Johnson (Switzerland)'s research output changed?
Output in 2018–2022 was 25% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Zug
- Varian Medical Systems (Switzerland)
- Biogen (Switzerland)
- University of Teacher Education Zug
- Amgen (Switzerland)
- AstraZeneca (Switzerland)
- RHI Magnesita (Switzerland)
- SHL Medical (Switzerland)
- Sucampo (Switzerland)
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.